Literature DB >> 3948660

Comparison of vitreous replacement with Healon and with HPMC in rabbits' eyes.

R Koster, J S Stilma.   

Abstract

Ten rabbits underwent vitreous aspiration and replacement by either Healon or Hydroxy Propyl Methyl Cellulose 2%. Four weeks' observation did not reveal noticeable differences between Healon and HPMC with regard to anterior chamber reaction, intra-ocular pressure or cataract. The vitreous reaction in eyes with HPMC was much more severe than in Healon eyes, with typical white precipitates and vitreous bands. Post-mortem examination confirmed the clinical findings.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948660     DOI: 10.1007/bf00142350

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  17 in total

1.  Unexpected traction retinal detachment: a complication of an animal model of pars plana vitrectomy.

Authors:  W A van der Zee; J S Lean; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

2.  Methylcellulose and lens implantation.

Authors:  P U Fechner; M U Fechner
Journal:  Br J Ophthalmol       Date:  1983-04       Impact factor: 4.638

3.  Chemical vitrectomy: change of solid gel vitreous to sol for vitrectomy by changing pH of vitreous toward the slight acid side.

Authors:  A Mortada
Journal:  Ann Ophthalmol       Date:  1982-05

4.  Vitreous management during secondary implantation.

Authors:  S L Pallin; G B Walman
Journal:  J Am Intraocul Implant Soc       Date:  1981

5.  Hyaluronate in aqueous humour.

Authors:  U B Laurent
Journal:  Exp Eye Res       Date:  1981-08       Impact factor: 3.467

6.  Replacement of the liquid vitreus with sodium hyaluronate in monkeys. II. Long-term evaluation.

Authors:  J L Denlinger; A A El-Mofty; E A Balazs
Journal:  Exp Eye Res       Date:  1980-07       Impact factor: 3.467

7.  [Initial experiences with Healon].

Authors:  M Zirm
Journal:  Klin Monbl Augenheilkd       Date:  1982-11       Impact factor: 0.700

8.  Safety and efficacy of 2% methylcellulose in cat and monkey cataract-implant surgery.

Authors:  S G Smith; R L Lindstrom; R A Miller; S Hazel; D Skelnik; P Williams; E Mindrup
Journal:  J Am Intraocul Implant Soc       Date:  1984

9.  Methylcellulose instead of Healon in extracapsular surgery with intraocular lens implantation.

Authors:  D Aron-Rosa; H C Cohn; J J Aron; C Bouquety
Journal:  Ophthalmology       Date:  1983-10       Impact factor: 12.079

10.  The effects of sodium hyaluronate, chondroitin sulfate, and methylcellulose on the corneal endothelium and intraocular pressure.

Authors:  S M Mac Rae; H F Edelhauser; R A Hyndiuk; E M Burd; R O Schultz
Journal:  Am J Ophthalmol       Date:  1983-03       Impact factor: 5.258

View more
  5 in total

1.  Experimental vitreous tamponade using polyalkylimide hydrogel.

Authors:  Sven Crafoord; Sten Andreasson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-31       Impact factor: 3.117

2.  Evaluation of viscoelastic poly(ethylene glycol) sols as vitreous substitutes in an experimental vitrectomy model in rabbits.

Authors:  Christopher D Pritchard; Sven Crafoord; Sten Andréasson; Karin M Arnér; Timothy M O'Shea; Robert Langer; Fredrik K Ghosh
Journal:  Acta Biomater       Date:  2010-11-24       Impact factor: 8.947

3.  A new model for in vitro testing of vitreous substitute candidates.

Authors:  Henrik Barth; Sven Crafoord; Timothy M O'Shea; Christopher D Pritchard; Robert Langer; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-25       Impact factor: 3.117

4.  Healon as intravitreal substitute in retinal detachment surgery in 40 patients.

Authors:  R Koster; J S Stilma
Journal:  Doc Ophthalmol       Date:  1986-12-30       Impact factor: 2.379

Review 5.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.